CLEPIC2026 will gather leading experts, clinicians, and industry innovators to share the latest advances in molecular and clinical epigenetics, with a special focus on cancer epigenetics.
We would also like to invite you to join our session “The 6-base genome unlocks novel mechanistic biomarkers and enhanced biological insight from challenging clinical samples”, where biomodal’s Scientific Affairs Partner Sascha Seidel show you how DNA methylation can be both activating (5hmC) and deactivating (5mC) depending on modification status.
Would you like to meet up in person? Book your onsite meeting with one of our biomodal attendees by filling out the form below. ⬇️
